Atopic Dermatitis Treatment Market - Forecast(2022 - 2027)

Report Code: HCR 0147 Report Format: PDF + Excel

Atopic Dermatitis Treatment Market Overview

The Atopic Dermatitis Treatment Market size is estimated to reach $24.8 billion by 2027. Furthermore, it is poised to grow at a CAGR of 12.3% over the forecast period of 2022-2027. Atopic dermatitis is an inflammatory disease affecting the skin and makes rashes-patches available on the neck-face and eyes in adults/children. Further, atopic eczema has become a proficient reason for ill-mental health, as children suffering from such conditions often feel left-out or distinct, thereby affecting their long-haul personality. The skin condition medications range from the use of corticosteroids to advancing biologics. The latter part, biologics, have been gaining immense market traction owing to their power to work at sub-molecular levels, without aggravating prior symptoms. It is rudimentary to know that skin barrier dysfunction forms the first reason for the development of atopic dermatitis. Moreover, serious complicating diseases such as eczema herpeticum affects people suffering from atopic dermatitis, the said condition occurs when the person encounters the herpes virus. The said rash treatment can be countered with antibiotics and other viral medications. The launch of new products within the market supplemented by the large, afflicted population pool has been recognized as the key factor driving the Atopic Dermatitis Industry forward in the projected period of 2022-2027.

Report Coverage

The report: Atopic Dermatitis Treatment Market Forecast (2022-2027)”, by Industry ARC covers an in-depth analysis of the following segments of the Atopic Dermatitis Treatment Market.

By Drug Type- Corticosteroids, Calcineurin Inhibitors, PDE4 inhibitors, Biologics, and others.
By Route of Administration- Topical and Oral.     
By Distribution Channel – Offline and Online Channel. 
By Geography- North America (U.S., Canada, Mexico), Europe (Germany, United Kingdom (U.K.), France, Italy, Spain, Russia, and Rest of Europe), Asia Pacific (China, Japan India, South Korea, Australia, and New Zealand, and Rest of Asia Pacific), South America (Brazil, Argentina, and Rest of South America), and Rest of the World (the Middle East, and Africa).

Key Takeaways

  • Geographically, North America’s atopic dermatitis treatment market held a dominant market share in the year 2021. It is owing to the high prevalence of the said condition within the discussed geography, moreover, prevalent pharmaceutical and biotech companies are present within the region which allows for deeper market penetration. However, Asia-Pacific is expected to offer lucrative growth opportunities to the marketers in the projected period of 2022-2027 owing to the rising numbers of CROs and other research organizations which are developing novel medicines and treatment procedures.
  • The launch of new products within the market supplemented by the large, afflicted population pool has been recognized as the key driver for Atopic Dermatitis Market. However, product recalls, the exponential increase of hypersensitive reaction, and a close-knitted competition have impeded the market growth.
  • A detailed analysis of strengths, weaknesses, opportunities, and threats will be provided in the Atopic Dermatitis Treatment Market Report.

Atopic Dermatitis Treatment Market- Geography (%) for 2021.

For More Details on This Report - Request for Sample

Atopic Dermatitis Treatment Market Segmentation Analysis- By Drug Type

The atopic dermatitis treatment market based on Drug Type can be further segmented into Corticosteroids, Calcineurin Inhibitors, PDE4 inhibitors, Biologics, and others. Corticosteroids held a dominant market share in the year 2021. It is owing to the wide prevalence and the first deterrent or line of defense for the treatment of the discussed condition. As per the preliminary studies, doctors recommend corticosteroid gels or ointments to start the treatment. Further, corticosteroid gels and ointment cost less, thereby making it popular in low-and middle-income countries.

However, the Biologics segment is estimated to be the fastest-growing, with a CAGR of 13.1% over the forecast period of 2022-2027. Biologics has been a growing field of study to treat cases where other lines of defense do not work such as by Corticosteroids and Calcineurin Inhibitors. Various randomized trials have been conducted; an interesting study found that the use of Baricitinib along with topical corticosteroids aided fruitful results in people suffering from moderate to severe atopic dermatitis. A randomized clinical trial of 329 adults with moderate to severe AD, as per the benchmarking, the combination treatment showed /achieved results of 31% differential (of patients receiving 4 mg of baricitinib with TCS therapy) and 24% of patients receiving 2 mg of baricitinib with TCS therapy compared with 15% receiving placebo with TCS therapy. Owing to such efficacy, the said segment would outpace the others.

Atopic Dermatitis Treatment Market Segmentation Analysis- By Distribution Channel

The atopic dermatitis treatment market based on distribution channels can be further segmented into offline and online channels. Offline held a dominant market share in the year 2021. It is owing to the treatments, particularly the injectables must be purchased via hospital pharmacies. In cases of severe cases of atopic dermatitis, doctors would have to provide corticosteroids via injection, as the medicine dissolved faster and provide effects within minutes. Moreover, retailer pharmacists provide ready discounts on repeated purchases of medication, thereby retaining a major proportion of consumers.

However, online channels are estimated to be the fastest-growing, with a CAGR of 13.2% over the forecast period of 2022-2027. It is owing to the widespread availability of the internet across geographies, with an additional impetus of new med-tech companies launching applications, which allows for easy medicine delivery and treatment. Further, independent discounts provided by third-party sellers allow the market to grow deeper. For example, on the TATA-1MG platform, Antonide-H Cream having hydrocortisone is available at a 20% discount on the MRP, further, a special discount on choosing online payment gives impetus to consumers to order.

Atopic Dermatitis Treatment Market Segmentation Analysis- By Geography

The Atopic Dermatitis Treatment market based on Geography can be further segmented into North America, Europe, Asia-Pacific, South America, and the Rest of the World. North America held a dominant market share of 33% as compared to the other regions in 2021. The predominant companies are headquartered in the USA, which gives an overall edge over the other regions. Further, companies (offering treatment medicines), on average allocated 15-20% of their revenue to R&D, which allows them to provide better offerings in the highly competitive market. Moreover, the US Government spends close to $4.1 trillion for healthcare, which gives a significant impetus to private companies.

However, Asia-Pacific is expected to offer lucrative growth opportunities to marketers in the projected period of 2022-2027. It is owing to the rising initiatives taken by the government to tackle the said disease by working at the top and bottom levels. Further, India saw an increment of 137% in its healthcare spending which would allow for better medical discoveries.

Atopic Dermatitis Treatment Market Drivers

A large patient pool afflicted by atopic dermatitis has been a key driver for the treatment’s market.

Atopic dermatitis usually begins during childhood and often involved genetic disorders-environmental-exposure-and immune system malfunctioning. The prevalence of atopic dermatitis in the majority of the regions is significantly high. For example, an association led by National Eczema Association found that 7.3% of the adults in the US were afflicted by atopic dermatitis, and about 40% had severe or moderate symptoms. Moreover, as per independent researchers, atopic dermatitis was highly prevalent in pediatrics. In 45% of the surveyed children, symptoms appear before 6 months, while 60% of the population develop symptoms before 1 year. Only a small proportion of atopic dermatitis is found in children aged between 6-20 years. The said trends continue to be followed around the globe. For example, in India, around 20% of the children have chance to develop AD within a year of birth. The high prevalence of the said condition has been a key driver for the market.

The upliftment of biologics has been a key driver for the treatment market.

Atopic dermatitis has been a prolonged condition, for which the field of biologics has continued to find solutions with minimal side effects. Owing to such needs, dupilumab was discovered and has proved effective results in those afflicted. A recently published article from Spain with data on 70 patients treated with dupilumab showed good efficacy regarding both skin condition and pruritus. In the said study, the condition improved by 60-70% after six months of treatment. Further, the studies which took place in Berlin showed, that after three months of the said treatment-32% of patients achieved a SCORAD of 75, and 67% achieved SCORAD50. Furthermore, the affected body surface area reduced from 42.17% to 9.9%. The said reduction further allows people to start the said treatment. Lastly, dupilumab has shown now cases of skin reactions or anaphylaxis.

Atopic Dermatitis Treatment Market Challenges

Product recalls the exponential increase of hypersensitive reaction, and a close knitted competition has impeded the market growth

Eczema treatments have often been recalled in the past, especially the topic mode. For example, a nationwide Class- III recall had been issued for 6763 1 Gram Novacort Gel Sample Packets. The said product contains 2% hydrocortisone acetate (a steroid), along with 1% pramoxine HCI. The reason given for the same is that the drug is sub potent, and out of specifications results for pramoxine hydrochloride were provided. Furthermore, Incyte reported cases where API issues were felt in small batches. Users lodged complaints about the texture of the cream. Moreover, Incyte says it will suspend its Opzelura sample program, but there is no product recall. Lastly, there has been increasing in cases where a topical medication led to serious ramifications, such as cases of anaphylaxis and others which has resulted in low confidence in the products.

Atopic Dermatitis Treatment Industry Outlook

Product launches, mergers and acquisitions, joint ventures, and geographical expansions are key strategies adopted by players in the Atopic Dermatitis Treatment Market. The top 10- Atopic Dermatitis Treatment Market companies are-

  1. Bayer,
  2. LEO Pharma,
  3. Mylan,
  4. Pfizer,
  5. Allergan Plc.,
  6. Novartis International AG,
  7. Bristol-Myers Squibb,
  8. Anacor Pharmaceutical Inc.,
  9. Astellas Pharma Inc.
  10. Sanofi

Recent Developments

  • In February 2021, UK Medical Association approved- abrocitinib. The said medicine contains an active substance, abrocitinob. Further, the medicine is a Janus kinase inhibitor that works by reducing the inflammation and itch in atopic dermatitis.  Abrocitinib is used to treat adults and adolescents 12 years of age and older with severe atopic dermatitis, also known as atopic eczema. Abrocitinib may be used with eczema medicines that you apply to the skin, or it may be used on its own.
  • In September 2020, European Medicines Agency agreed to a new oral treatment for moderate to severe atopic dermatitis. Earlier, Olumiant was already approved in the European Union to treat moderate to severely active rheumatoid arthritis, a disease-causing inflammation of the joints. Further, EMA has recommended granting an extension of indication to Olumiant (baricitinib) to include the treatment of moderate to severe atopic dermatitis in adult patients who are candidates for systemic therapy.
  • In May 2020, Sanofi received FDA approval for DUPIXENT- Dupilumab, as the first biologic medicine for children aged between 6-11 and who have moderate to severe atopic dermatitis. Three-quarters of patients receiving Dupixent achieved at least a 75% improvement in overall disease, with an average improvement of approximately 80%. The said medication must only start once the patient shows no improvement via topical treatments.

Relevant Titles

Hydrocortisone Market- Forecast (2022-2027)

Report Code- CMR 0992

Atopic Drugs Market- Forecast (2022-2027)

Report Code- HCR 98243

For more Lifesciences and Healthcare Market reports, please click here

Table of Contents

1. Atopic Dermatitis Treatment Market Overview
    1.1 Definitions and Scope
2. Atopic Dermatitis Treatment Market- Executive Summary
3. Atopic Dermatitis Treatment Market – Market Landscape
    3.1 Company Benchmarking- Key Companies
    3.2 Key Company Financial Analysis
    3.3 Market Share Analysis
    3.4 Patent Analysis
    3.5 Pricing Analysis (Comparison of General Price Offerings in the Market)
4. Atopic Dermatitis Treatment Market – Startup Company Scenario (Premium)
    4.1 Investment
    4.2 Revenue
    4.3 Venture Capital and Funding Scenario
5. Atopic Dermatitis Treatment Market – Industry Market Entry Scenario Premium (Premium)
    5.1 Regulatory Scenario
    5.2 New Business and Ease of Doing business index
    5.3 Case Studies of Successful Ventures
6. Atopic Dermatitis Treatment Market - Market Forces
    6.1 Market Drivers
    6.2 Market Constraints
    6.3 Porters five force model
        6.3.1 Bargaining power of suppliers
        6.3.2 Bargaining powers of customers
        6.3.3 Threat of new entrants
        6.3.4 Rivalry among existing players
        6.3.5 Threat of substitutes
7. Atopic Dermatitis Treatment Market – By Strategic Analysis
    7.1 Value Chain Analysis
    7.2 Opportunities Analysis
    7.3 Market Life Cycle Analysis
8. Atopic Dermatitis Treatment Market- By Drug Type (Market Size –$Million/$Billion) 
    8.1 Corticosteroids
    8.2 Calcineurin Inhibitors
    8.3 PDE4 Inhibitors
    8.4 Biologics
    8.5 Others
9. Atopic Dermatitis Treatment Market- By Route of Administration (Market Size –$Million/$Billion) 
    9.1 Topical
    9.2 Oral
    9.3 Injectable
10. Atopic Dermatitis Treatment Market- By Distribution Channel (Market Size –$Million/$Billion) 
    10.1 Offline Channel
        10.1.1 Hospital Pharmacy
        10.1.2 Retail Pharmacy
        10.1.3 Drug Stores
        10.1.4 Others
    10.2 Online Channel
11. Atopic Dermatitis Treatment Market - By Geography (Market Size -$Million/Billion)
    11.1 North America
        11.1.1 U.S
        11.1.2 Canada
        11.1.3 Mexico
    11.2 Europe
        11.2.1 Germany
        11.2.2 France
        11.2.3 UK
        11.2.4 Italy
        11.2.5 Spain
        11.2.6 Russia
        11.2.7 Rest of Europe
    11.3 Asia-Pacific
        11.3.1 China
        11.3.2 Japan
        11.3.3 South Korea
        11.3.4 India
        11.3.5 Australia & New Zealand
        11.3.6 Rest of APAC
    11.4 South America
        11.4.1 Brazil
        11.4.2 Argentina
        11.4.3 Chile
        11.4.4 Colombia
        11.4.5 Rest of South America
    11.5 Rest of the World
        11.5.1 Middle East
        11.5.2 Africa
12. Atopic Dermatitis Treatment Market - Market Entropy
    12.1 New product launches
    12.2 M&A's, collaborations, JVs and partnerships
13. Atopic Dermatitis Treatment Market – Industry Competition Landscape (Premium)
    13.1 Market Share Analysis
        13.1.1 Global Market Share – Key Companies
        13.1.2 Market Share by Region – Key Companies
        13.1.3 Market Share by Countries – Key Companies
    13.2 Competition Matrix
    13.3 Best Practices for Companies
14. Atopic Dermatitis Treatment Market – Key Company List by Country Premium (Premium)
15. Atopic Dermatitis Treatment Market - Company Analysis
    15.1 Company 1
    15.2 Company 2
    15.3 Company 3
    15.4 Company 4
    15.5 Company 5
    15.6 Company 6
    15.7 Company 7
    15.8 Company 8
    15.9 Company 9
    15.10 Company 10

"*Financials would be provided on a best-efforts basis for private companies
List of Tables:

Table 1: Atopic Dermatitis Treatment Market Overview 2021-2026
Table 2: Atopic Dermatitis Treatment Market Leader Analysis 2018-2019 (US$)
Table 3: Atopic Dermatitis Treatment Market Product Analysis 2018-2019 (US$)
Table 4: Atopic Dermatitis Treatment Market End User Analysis 2018-2019 (US$)
Table 5: Atopic Dermatitis Treatment Market Patent Analysis 2013-2018* (US$)
Table 6: Atopic Dermatitis Treatment Market Financial Analysis 2018-2019 (US$)
Table 7: Atopic Dermatitis Treatment Market Driver Analysis 2018-2019 (US$)
Table 8: Atopic Dermatitis Treatment Market Challenges Analysis 2018-2019 (US$)
Table 9: Atopic Dermatitis Treatment Market Constraint Analysis 2018-2019 (US$)
Table 10: Atopic Dermatitis Treatment Market Supplier Bargaining Power Analysis 2018-2019 (US$)
Table 11: Atopic Dermatitis Treatment Market Buyer Bargaining Power Analysis 2018-2019 (US$)
Table 12: Atopic Dermatitis Treatment Market Threat of Substitutes Analysis 2018-2019 (US$)
Table 13: Atopic Dermatitis Treatment Market Threat of New Entrants Analysis 2018-2019 (US$)
Table 14: Atopic Dermatitis Treatment Market Degree of Competition Analysis 2018-2019 (US$)
Table 15: Atopic Dermatitis Treatment Market Value Chain Analysis 2018-2019 (US$)
Table 16: Atopic Dermatitis Treatment Market Pricing Analysis 2021-2026 (US$)
Table 17: Atopic Dermatitis Treatment Market Opportunities Analysis 2021-2026 (US$)
Table 18: Atopic Dermatitis Treatment Market Product Life Cycle Analysis 2021-2026 (US$)
Table 19: Atopic Dermatitis Treatment Market Supplier Analysis 2018-2019 (US$)
Table 20: Atopic Dermatitis Treatment Market Distributor Analysis 2018-2019 (US$)
Table 21: Atopic Dermatitis Treatment Market Trend Analysis 2018-2019 (US$)
Table 22: Atopic Dermatitis Treatment Market Size 2018 (US$)
Table 23: Atopic Dermatitis Treatment Market Forecast Analysis 2021-2026 (US$)
Table 24: Atopic Dermatitis Treatment Market Sales Forecast Analysis 2021-2026 (Units)
Table 25: Atopic Dermatitis Treatment Market, Revenue & Volume,By Type of Treatment, 2021-2026 ($)
Table 26: Atopic Dermatitis Treatment Market By Type of Treatment, Revenue & Volume,By Topical Corticosteroids, 2021-2026 ($)
Table 27: Atopic Dermatitis Treatment Market By Type of Treatment, Revenue & Volume,By Immunosuppressant, 2021-2026 ($)
Table 28: North America Atopic Dermatitis Treatment Market, Revenue & Volume,By Type of Treatment, 2021-2026 ($)
Table 29: South america Atopic Dermatitis Treatment Market, Revenue & Volume,By Type of Treatment, 2021-2026 ($)
Table 30: Europe Atopic Dermatitis Treatment Market, Revenue & Volume,By Type of Treatment, 2021-2026 ($)
Table 31: APAC  Atopic Dermatitis Treatment Market, Revenue & Volume,By Type of Treatment, 2021-2026 ($)
Table 32: Middle East & Africa Atopic Dermatitis Treatment Market, Revenue & Volume,By Type of Treatment, 2021-2026 ($)
Table 33: Russia Atopic Dermatitis Treatment Market, Revenue & Volume,By Type of Treatment, 2021-2026 ($)
Table 34: Israel Atopic Dermatitis Treatment Market, Revenue & Volume,By Type of Treatment, 2021-2026 ($)
Table 35: Top Companies 2018 (US$) Atopic Dermatitis Treatment Market, Revenue & Volume
Table 36: Product Launch 2018-2019 Atopic Dermatitis Treatment Market, Revenue & Volume
Table 37: Mergers & Acquistions 2018-2019 Atopic Dermatitis Treatment Market, Revenue & Volume


List of Figures:

Figure 1: Overview of Atopic Dermatitis Treatment Market 2021-2026
Figure 2: Market Share Analysis for Atopic Dermatitis Treatment Market 2018 (US$)
Figure 3: Product Comparison in Atopic Dermatitis Treatment Market 2018-2019 (US$)
Figure 4: End User Profile for Atopic Dermatitis Treatment Market 2018-2019 (US$)
Figure 5: Patent Application and Grant in Atopic Dermatitis Treatment Market 2013-2018* (US$)
Figure 6: Top 5 Companies Financial Analysis in Atopic Dermatitis Treatment Market 2018-2019 (US$)
Figure 7: Market Entry Strategy in Atopic Dermatitis Treatment Market 2018-2019
Figure 8: Ecosystem Analysis in Atopic Dermatitis Treatment Market 2018
Figure 9: Average Selling Price in Atopic Dermatitis Treatment Market 2021-2026
Figure 10: Top Opportunites in Atopic Dermatitis Treatment Market 2018-2019
Figure 11: Market Life Cycle Analysis in Atopic Dermatitis Treatment Market
Figure 12: Global By Type of Treatment Atopic Dermatitis Treatment Market Revenue, 2021-2026 ($)
Figure 13: Global Atopic Dermatitis Treatment Market - By Geography
Figure 14: Global Atopic Dermatitis Treatment Market Value & Volume, By Geography, 2021-2026 ($) 
Figure 15: Global Atopic Dermatitis Treatment Market CAGR, By Geography, 2021-2026 (%)
Figure 16: North America Atopic Dermatitis Treatment Market Value & Volume, 2021-2026 ($)
Figure 17: US Atopic Dermatitis Treatment Market Value & Volume, 2021-2026 ($)
Figure 18: US GDP and Population, 2018-2019 ($)
Figure 19: US GDP – Composition of 2018, By Sector of Origin
Figure 20: US Export and Import Value & Volume, 2018-2019 ($)
Figure 21: Canada Atopic Dermatitis Treatment Market Value & Volume, 2021-2026 ($)
Figure 22: Canada GDP and Population, 2018-2019 ($)
Figure 23: Canada GDP – Composition of 2018, By Sector of Origin
Figure 24: Canada Export and Import Value & Volume, 2018-2019 ($)
Figure 25: Mexico Atopic Dermatitis Treatment Market Value & Volume, 2021-2026 ($)
Figure 26: Mexico GDP and Population, 2018-2019 ($)
Figure 27: Mexico GDP – Composition of 2018, By Sector of Origin
Figure 28: Mexico Export and Import Value & Volume, 2018-2019 ($)
Figure 29: South America Atopic Dermatitis Treatment Market South America 3D Printing  Market Value & Volume, 2021-2026 ($)
Figure 30: Brazil Atopic Dermatitis Treatment Market Value & Volume, 2021-2026 ($)
Figure 31: Brazil GDP and Population, 2018-2019 ($)
Figure 32: Brazil GDP – Composition of 2018, By Sector of Origin
Figure 33: Brazil Export and Import Value & Volume, 2018-2019 ($)
Figure 34: Venezuela Atopic Dermatitis Treatment Market Value & Volume, 2021-2026 ($)
Figure 35: Venezuela GDP and Population, 2018-2019 ($)
Figure 36: Venezuela GDP – Composition of 2018, By Sector of Origin
Figure 37: Venezuela Export and Import Value & Volume, 2018-2019 ($)
Figure 38: Argentina Atopic Dermatitis Treatment Market Value & Volume, 2021-2026 ($)
Figure 39: Argentina GDP and Population, 2018-2019 ($)
Figure 40: Argentina GDP – Composition of 2018, By Sector of Origin
Figure 41: Argentina Export and Import Value & Volume, 2018-2019 ($)
Figure 42: Ecuador Atopic Dermatitis Treatment Market Value & Volume, 2021-2026 ($)
Figure 43: Ecuador GDP and Population, 2018-2019 ($)
Figure 44: Ecuador GDP – Composition of 2018, By Sector of Origin
Figure 45: Ecuador Export and Import Value & Volume, 2018-2019 ($)
Figure 46: Peru Atopic Dermatitis Treatment Market Value & Volume, 2021-2026 ($)
Figure 47: Peru GDP and Population, 2018-2019 ($)
Figure 48: Peru GDP – Composition of 2018, By Sector of Origin
Figure 49: Peru Export and Import Value & Volume, 2018-2019 ($)
Figure 50: Colombia Atopic Dermatitis Treatment Market Value & Volume, 2021-2026 ($)
Figure 51: Colombia GDP and Population, 2018-2019 ($)
Figure 52: Colombia GDP – Composition of 2018, By Sector of Origin
Figure 53: Colombia Export and Import Value & Volume, 2018-2019 ($)
Figure 54: Costa Rica Atopic Dermatitis Treatment MarketCosta Rica 3D Printing  Market Value & Volume, 2021-2026 ($)
Figure 55: Costa Rica GDP and Population, 2018-2019 ($)
Figure 56: Costa Rica GDP – Composition of 2018, By Sector of Origin
Figure 57: Costa Rica Export and Import Value & Volume, 2018-2019 ($)
Figure 58: Europe Atopic Dermatitis Treatment Market Value & Volume, 2021-2026 ($)
Figure 59: U.K Atopic Dermatitis Treatment Market Value & Volume, 2021-2026 ($)
Figure 60: U.K GDP and Population, 2018-2019 ($)
Figure 61: U.K GDP – Composition of 2018, By Sector of Origin
Figure 62: U.K Export and Import Value & Volume, 2018-2019 ($)
Figure 63: Germany Atopic Dermatitis Treatment Market Value & Volume, 2021-2026 ($)
Figure 64: Germany GDP and Population, 2018-2019 ($)
Figure 65: Germany GDP – Composition of 2018, By Sector of Origin
Figure 66: Germany Export and Import Value & Volume, 2018-2019 ($)
Figure 67: Italy Atopic Dermatitis Treatment Market Value & Volume, 2021-2026 ($)
Figure 68: Italy GDP and Population, 2018-2019 ($)
Figure 69: Italy GDP – Composition of 2018, By Sector of Origin
Figure 70: Italy Export and Import Value & Volume, 2018-2019 ($)
Figure 71: France Atopic Dermatitis Treatment Market Value & Volume, 2021-2026 ($)
Figure 72: France GDP and Population, 2018-2019 ($)
Figure 73: France GDP – Composition of 2018, By Sector of Origin
Figure 74: France Export and Import Value & Volume, 2018-2019 ($)
Figure 75: Netherlands Atopic Dermatitis Treatment Market Value & Volume, 2021-2026 ($)
Figure 76: Netherlands GDP and Population, 2018-2019 ($)
Figure 77: Netherlands GDP – Composition of 2018, By Sector of Origin
Figure 78: Netherlands Export and Import Value & Volume, 2018-2019 ($)
Figure 79: Belgium Atopic Dermatitis Treatment Market Value & Volume, 2021-2026 ($)
Figure 80: Belgium GDP and Population, 2018-2019 ($)
Figure 81: Belgium GDP – Composition of 2018, By Sector of Origin
Figure 82: Belgium Export and Import Value & Volume, 2018-2019 ($)
Figure 83: Spain Atopic Dermatitis Treatment Market Value & Volume, 2021-2026 ($)
Figure 84: Spain GDP and Population, 2018-2019 ($)
Figure 85: Spain GDP – Composition of 2018, By Sector of Origin
Figure 86: Spain Export and Import Value & Volume, 2018-2019 ($)
Figure 87: Denmark Atopic Dermatitis Treatment Market Value & Volume, 2021-2026 ($)
Figure 88: Denmark GDP and Population, 2018-2019 ($)
Figure 89: Denmark GDP – Composition of 2018, By Sector of Origin
Figure 90: Denmark Export and Import Value & Volume, 2018-2019 ($)
Figure 91: APAC Atopic Dermatitis Treatment Market Value & Volume, 2021-2026 ($)
Figure 92: China Atopic Dermatitis Treatment MarketValue & Volume, 2021-2026
Figure 93: China GDP and Population, 2018-2019 ($)
Figure 94: China GDP – Composition of 2018, By Sector of Origin
Figure 95: China Export and Import Value & Volume, 2018-2019 ($)Atopic Dermatitis Treatment MarketChina Export and Import Value & Volume, 2018-2019 ($)
Figure 96: Australia Atopic Dermatitis Treatment Market Value & Volume, 2021-2026 ($)
Figure 97: Australia GDP and Population, 2018-2019 ($)
Figure 98: Australia GDP – Composition of 2018, By Sector of Origin
Figure 99: Australia Export and Import Value & Volume, 2018-2019 ($)
Figure 100: South Korea Atopic Dermatitis Treatment Market Value & Volume, 2021-2026 ($)
Figure 101: South Korea GDP and Population, 2018-2019 ($)
Figure 102: South Korea GDP – Composition of 2018, By Sector of Origin
Figure 103: South Korea Export and Import Value & Volume, 2018-2019 ($)
Figure 104: India Atopic Dermatitis Treatment Market Value & Volume, 2021-2026 ($)
Figure 105: India GDP and Population, 2018-2019 ($)
Figure 106: India GDP – Composition of 2018, By Sector of Origin
Figure 107: India Export and Import Value & Volume, 2018-2019 ($)
Figure 108: Taiwan Atopic Dermatitis Treatment MarketTaiwan 3D Printing  Market Value & Volume, 2021-2026 ($)
Figure 109: Taiwan GDP and Population, 2018-2019 ($)
Figure 110: Taiwan GDP – Composition of 2018, By Sector of Origin
Figure 111: Taiwan Export and Import Value & Volume, 2018-2019 ($)
Figure 112: Malaysia Atopic Dermatitis Treatment MarketMalaysia 3D Printing  Market Value & Volume, 2021-2026 ($)
Figure 113: Malaysia GDP and Population, 2018-2019 ($)
Figure 114: Malaysia GDP – Composition of 2018, By Sector of Origin
Figure 115: Malaysia Export and Import Value & Volume, 2018-2019 ($)
Figure 116: Hong Kong Atopic Dermatitis Treatment MarketHong Kong 3D Printing  Market Value & Volume, 2021-2026 ($)
Figure 117: Hong Kong GDP and Population, 2018-2019 ($)
Figure 118: Hong Kong GDP – Composition of 2018, By Sector of Origin
Figure 119: Hong Kong Export and Import Value & Volume, 2018-2019 ($)
Figure 120: Middle East & Africa Atopic Dermatitis Treatment MarketMiddle East & Africa 3D Printing  Market Value & Volume, 2021-2026 ($)
Figure 121: Russia Atopic Dermatitis Treatment MarketRussia 3D Printing  Market Value & Volume, 2021-2026 ($)
Figure 122: Russia GDP and Population, 2018-2019 ($)
Figure 123: Russia GDP – Composition of 2018, By Sector of Origin
Figure 124: Russia Export and Import Value & Volume, 2018-2019 ($)
Figure 125: Israel Atopic Dermatitis Treatment Market Value & Volume, 2021-2026 ($)
Figure 126: Israel GDP and Population, 2018-2019 ($)
Figure 127: Israel GDP – Composition of 2018, By Sector of Origin
Figure 128: Israel Export and Import Value & Volume, 2018-2019 ($)
Figure 129:  Entropy Share, By Strategies, 2018-2019* (%)Atopic Dermatitis Treatment Market
Figure 130:  Developments, 2018-2019*Atopic Dermatitis Treatment Market
Figure 131: Company 1 Atopic Dermatitis Treatment Market Net Revenue, By Years, 2018-2019* ($)
Figure 132: Company 1 Atopic Dermatitis Treatment Market Net Revenue Share, By Business segments, 2018 (%)
Figure 133: Company 1 Atopic Dermatitis Treatment Market Net Sales Share, By Geography, 2018 (%)
Figure 134: Company 2 Atopic Dermatitis Treatment Market Net Revenue, By Years, 2018-2019* ($)
Figure 135: Company 2 Atopic Dermatitis Treatment Market Net Revenue Share, By Business segments, 2018 (%)
Figure 136: Company 2 Atopic Dermatitis Treatment Market Net Sales Share, By Geography, 2018 (%)
Figure 137: Company 3Atopic Dermatitis Treatment Market Net Revenue, By Years, 2018-2019* ($)
Figure 138: Company 3Atopic Dermatitis Treatment Market Net Revenue Share, By Business segments, 2018 (%)
Figure 139: Company 3Atopic Dermatitis Treatment Market Net Sales Share, By Geography, 2018 (%)
Figure 140: Company 4 Atopic Dermatitis Treatment Market Net Revenue, By Years, 2018-2019* ($)
Figure 141: Company 4 Atopic Dermatitis Treatment Market Net Revenue Share, By Business segments, 2018 (%)
Figure 142: Company 4 Atopic Dermatitis Treatment Market Net Sales Share, By Geography, 2018 (%)
Figure 143: Company 5 Atopic Dermatitis Treatment Market Net Revenue, By Years, 2018-2019* ($)
Figure 144: Company 5 Atopic Dermatitis Treatment Market Net Revenue Share, By Business segments, 2018 (%)
Figure 145: Company 5 Atopic Dermatitis Treatment Market Net Sales Share, By Geography, 2018 (%)
Figure 146: Company 6 Atopic Dermatitis Treatment Market Net Revenue, By Years, 2018-2019* ($)
Figure 147: Company 6 Atopic Dermatitis Treatment Market Net Revenue Share, By Business segments, 2018 (%)
Figure 148: Company 6 Atopic Dermatitis Treatment Market Net Sales Share, By Geography, 2018 (%)
Figure 149: Company 7 Atopic Dermatitis Treatment Market  Net Revenue, By Years, 2018-2019* ($)
Figure 150: Company 7 Atopic Dermatitis Treatment Market  Net Revenue Share, By Business segments, 2018 (%)
Figure 151: Company 7 Atopic Dermatitis Treatment Market  Net Sales Share, By Geography, 2018 (%)
Figure 152: Company 8 Atopic Dermatitis Treatment Market  Net Revenue, By Years, 2018-2019* ($)
Figure 153: Company 8 Atopic Dermatitis Treatment Market  Net Revenue Share, By Business segments, 2018 (%)
Figure 154: Company 8 Atopic Dermatitis Treatment Market  Net Sales Share, By Geography, 2018 (%)
Figure 155: Company 9 Atopic Dermatitis Treatment Market  Net Revenue, By Years, 2018-2019* ($)
Figure 156: Company 9 Atopic Dermatitis Treatment Market  Net Revenue Share, By Business segments, 2018 (%)
Figure 157: Company 9 Atopic Dermatitis Treatment Market  Net Sales Share, By Geography, 2018 (%)
Figure 158: Company 10 Atopic Dermatitis Treatment Market  Net Revenue, By Years, 2018-2019* ($)
Figure 159: Company 10 Atopic Dermatitis Treatment Market  Net Revenue Share, By Business segments, 2018 (%)
Figure 160: Company 10 Atopic Dermatitis Treatment Market  Net Sales Share, By Geography, 2018 (%)
Figure 161: Company 11 Atopic Dermatitis Treatment Market  Net Revenue, By Years, 2018-2019* ($)
Figure 162: Company 11 Atopic Dermatitis Treatment Market  Net Revenue Share, By Business segments, 2018 (%)
Figure 163: Company 11 Atopic Dermatitis Treatment Market  Net Sales Share, By Geography, 2018 (%)
Figure 164: Company 12 Atopic Dermatitis Treatment Market  Net Revenue, By Years, 2018-2019* ($)
Figure 165: Company 12 Atopic Dermatitis Treatment Market  Net Revenue Share, By Business segments, 2018 (%)
Figure 166: Company 12 Atopic Dermatitis Treatment Market  Net Sales Share, By Geography, 2018 (%)
Figure 167: Company 13 Atopic Dermatitis Treatment Market  Net Revenue, By Years, 2018-2019* ($)
Figure 168: Company 13 Atopic Dermatitis Treatment Market Net Revenue Share, By Business segments, 2018 (%)
Figure 169: Company 13 Atopic Dermatitis Treatment Market  Net Sales Share, By Geography, 2018 (%)
Figure 170: Company 14 Atopic Dermatitis Treatment Market  Net Revenue, By Years, 2018-2019* ($)
Figure 171: Company 14 Atopic Dermatitis Treatment Market  Net Revenue Share, By Business segments, 2018 (%)
Figure 172: Company 14 Atopic Dermatitis Treatment Market  Net Sales Share, By Geography, 2018 (%)
Figure 173: Company 15 Atopic Dermatitis Treatment Market  Net Revenue, By Years, 2018-2019* ($)
Figure 174: Company 15 Atopic Dermatitis Treatment Market  Net Revenue Share, By Business segments, 2018 (%)
Figure 175: Company 15 Atopic Dermatitis Treatment Market  Net Sales Share, By Geography, 2018 (%)